LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...

Digital device use and reading distance are linked to changes in choroidal thickness among Tokyo children. The study finds ...

Discover why Type 2 diabetes progression remains undetectable. Learn 8 silent processes that damage your body without warning signs or symptoms.

In a moment that drew applause and admiration from Ghana’s top business and political leaders, Dr. Michael Ekuoba Gyasi, ...

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

From preventative screening to specialist surgery, these leading consultants are helping patients take charge of their health ...

Veena Delivery Systems Inc. ("iVeena"), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced the submission of an Investigational New Drug (IND) ...

MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: ...

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

In a moment that drew applause and admiration from Ghana’s top business and political leaders, Dr. Michael Ekuoba Gyasi, Executive Director of St. Thomas ...

The Ipsos poll interviewed 1,501 people online on behalf of the Canadian Ophthalmological Society, and found that ...